GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...

GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...

At its Unpacked event, Samsung showed off its upcoming "Project Moohan" AR/VR headset, which is designed to compete with the Vision Pro. Some users might even mistake the headset for a Vision Pro ...

The new Octavia vRS is powered by a 2-litre turbo-petrol engine that cranks out a whopping 265 PS, making it the most powerful iteration of the sedan yet Gets LED matrix beam headlights ...

The tech rumoured to be in the headset so far, combined with Asus ROG's approach to computers implies that this will be a relatively high-end VR headset, and that could make it a formidable ...

The best VR headsets can make you forget, even if just for a moment, you're wearing a big chunk of plastic and foam on your face. It will make you feel like you're a part of a game's world ...

Among these, is the Octavia vRS. Designed for performance, the sedan has evolved through various generations before making it to India in its current state. The Skoda Octavia vRS comes with the ...

president of R&D at GSK and Pfizer’s Mikael Dolsten. These leaders represent respectively a Switzerland, France (EU), UK and US headquartered firms - but an uninterrupted flow of decisions at ...